In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes

European Journal of Preventive Cardiology

Volumn 17, Issue 4, 2010, Pages 419-423

  Lazzeri, Chiara ^a   Valente, Serafina ^a   Chiostri, Marco ^a   Picariello, Claudio ^a   Gian Franco, Gensini ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

acute ST segment elevation myocardial infarction; in hospital mortality; nondiabetic

Indexed keywords

GLUCOSE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; CORONARY CARE UNITS; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULIN; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 77955472701     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e328335f26f     Document Type: Article

References (26)

1. Opie LH. Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia. Circulation 2008; 117: 2172–2177.
2. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T etal; American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117: 1610–1619.
3. Mak K, Mah P, Tey B, Sin F, Chia G. Fasting blood sugar level: a determinant for in hospital outcome in patients with first myocardial infarction and without glucose intolerance. Ann Acad Med Singapore 1993; 22: 291–295.
4. Oswald G, Smith C, Betteridge J, Yudkin J. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ 1986; 293: 917–922.
5. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003; 31: 359–366.
6. Lazzeri C, Tarquini R, Giunta F, Gensini G.F., Glucose dysmetabolism and prognosis in critical illness. Intern Emerg Med 2009; 4: 147–156.
7. Buiatti E, Barchielli A, Marchionni N, Balzi D, Carrabba N, Valente S, et al Determinants of treatment strategies and survival in acute myocardial infarction: a population-based study in the Florence district, Italy: results of the acute myocardial infarction Florence registry (AMI-Florence). Eur Heart J 2003; 24: 1195–1203.
8. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503–1516.
9. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined. J Am Coll Cardiol 2000; 36: 959–969.
10. Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, et al Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol 2007; 114: 176–182.
11. Valente S, Lazzeri C, Chiostri M, Giglioli C, Sori A, Tigli S, et al NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol 2009; 132: 84–89.
12. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111: 754–760.
13. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005; 26: 1255–1261.
14. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, et al Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006; 27: 1289–1297.
15. Kosiborod M, Rathore SS, Inzucchi SE, Maoudi FA, Wang Y, Havranek EP, Krumholz HM. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078–3086.
16. Malmberg K DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997; 314: 1512–1515.
17. Cheung NW, Wong VW, McLean M. The hyperglycemia: intensive insulin infusion in infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006; 29: 765–770.
18. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D etal; CREATE-ECLA Trial Group. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293: 437–446.
19. Lefebvre PJ, Scheen AJ. The postprandial state and risk of cardiovascular disease. Diabet Med 1998; 15 (Suppl 4):S63–S68.
20. Cubbon RM, Rajwani A, Abbas A, Gale CP, Grant PJ, Wheatcroft SB, et al Hyperglycemia, in relation to sex, and mortality after coronary syndrome. Eur J Cardiovasc Prev Rehabil 2007; 14: 666–671.
21. Boas Soja AM, Zwisler AD, Melchior T, Hommel E, Torp-Pedersen C, Madsen M. Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study. Eur J Cardiovasc Prev Rehabil 2006; 13: 784–790.
22. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, et al Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008; 117: 1018–1027.
23. Ceriello A, Zarich SW, Testa R. Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. J Am Coll Cardiol 2009; 53: S9–S13.
24. Lazzeri C, Sori A, Chiostri M, Gensini GF, Valente S. Prognostic role of insulin-resistance as assessed by HOMA-Index in the acute phase of acute myocardial infarction in non-diabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol 2009; 26: 856–862.
25. Kosiborod M, Inzucchi SE, Krumholz HM, Masoudi FA, Goyal A, Xiao L, et al Glucose normalization and outcomes in patients with acute myocardial infarction. Arch Intern Med 2009; 169: 438–446.
26. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26: 650–661.